Management of locally advanced adenocarcinoma of the pancreas.

Published

Journal Article (Review)

Pancreatic cancer is one of the deadliest malignancies and is fatal in more than 95% of affected individuals. For locally advanced disease, the combination of 5-FU and radiation appears to offer the best chance for delaying disease progression. The introduction of gemcitabine into chemoradiotherapy regimens may provide additional improvements in the management of patients. Preoperative therapy has proved feasible but has not shown improvement in overall survival.

Full Text

Duke Authors

Cited Authors

  • Ryan, DP; Willett, CG

Published Date

  • February 2002

Published In

Volume / Issue

  • 16 / 1

Start / End Page

  • 95 - 103

PubMed ID

  • 12063831

Pubmed Central ID

  • 12063831

International Standard Serial Number (ISSN)

  • 0889-8588

Language

  • eng

Conference Location

  • United States